Facebook
  1. Home
  2. Solutions
  3. Early Clinical
  4. Bioanalytical Laboratories

Bioanalytical laboratories

Innovative method development and high-quality analytical services.

The world of clinical development is both complex and dynamic, which presents both research and development challenges for the pharmaceutical and biotech industry. ICON has a global network of specially designed laboratories dedicated to drug development solutions that meet those challenges.

  • 580+

    Bioanalysis experts across the world

  • 1500*

    Validated assays

  • 6680*

    Studies supported

* last 5 years

We apply integrated medical, scientific and operational excellence that’s essential for reaching decision milestones on-time and with the highest quality and regulatory insights.

We offer the highest quality services for pharmacokinetic, immunogenicity, biomarker, and CMC analysis, utilising a wide range of platforms for small molecules, large molecules, and cell-based entities.

Our three GLP, GCP and GMP compliant laboratories are strategically co-located with ICON’s early phase clinical research units to foster innovative, cross-functional team collaboration and to facilitate the rapid analyses of time-critical samples, and support fast dose escalations that are so crucial in today’s adaptive trials.

Find out more about ICON's bioanalytical laboratory solutions here. 

In this section

Connect with us